Selective serotonin reuptake inhibitors use in pregnancy: a risk assessment study using administrative pharmaceutical data

Background Antidepressant management with Selective Serotonin Reuptake Inhibitors (SSRI) during pregnancy is associated with risks of congenital malformations and adverse pregnancy outcomes. Main Aim We examined the incidence of SSRI use during pregnancy using Australian administrative pharmaceut...

Full description

Bibliographic Details
Main Authors: Shaun Purkiss, Tessa Keegel, Hassan Vally, Dennis Wollersheim
Format: Article
Language:English
Published: Swansea University 2019-11-01
Series:International Journal of Population Data Science
Online Access:https://ijpds.org/article/view/1167